⌘K
Loading ticker…
Invesco S&P SmallCap Health Care ETF · Financials · Trading
3m RS is unavailable, Market Stance is 47.8
As of 2026-08-24, Invesco S&P SmallCap Health Care ETF (PSCH) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Financials, ranked 4 of 11. Average daily range 1.2%, relative volume 1.18×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
| # | Holding | Weight | Value |
|---|---|---|---|
| 1 | MOH | 4.77% | $6M |
| 2 | BTSG | 4.35% | $6M |
| 3 | KRYS | 4.25% | $6M |
| 4 | ALKS | 3.71% | $5M |
| 5 | CORT | 3.47% | $5M |
| 6 | GKOS | 3.17% | $4M |
| 7 | PTCT | 3.16% | $4M |
| 8 | Protagonist Therapeutics, Inc. | 3.12% | $4M |
| 9 | TFX | 3.03% | $4M |
| 10 | TGTX | 2.75% | $4M |
| 11 | LGND | 2.43% | $3M |
| 12 | INDV | 2.40% | $3M |
| 13 | RDNT | 2.06% | $3M |
| 14 | MMSI | 1.99% | $3M |
| 15 | VCYT | 1.95% | $3M |
| 16 | CPRX | 1.92% | $3M |
| 17 | OGN | 1.85% | $2M |
| 18 | ICUI | 1.78% | $2M |
| 19 | ITGR | 1.67% | $2M |
| 20 | CON | 1.58% | $2M |
| 21 | ACAD | 1.45% | $2M |
| 22 | SUPN | 1.41% | $2M |
| 23 | PRVA | 1.33% | $2M |
| 24 | ALHC | 1.31% | $2M |
| 25 | TMDX | 1.22% | $2M |
Showing 25 of 76 holdings.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PSCH Jan avg: 2.50% median: 3.20% win: 75% σ: 5.27% n: 4 2022-04-12 → 2026-07-31 | PSCH Feb avg: -2.20% median: -2.38% win: 25% σ: 4.18% n: 4 2022-04-12 → 2026-07-31 | PSCH Mar avg: -1.95% median: -2.95% win: 25% σ: 3.61% n: 4 2022-04-12 → 2026-07-31 | PSCH Apr avg: -2.28% median: -4.67% win: 40% σ: 7.26% n: 5 2022-04-12 → 2026-07-31 | PSCH May avg: -0.33% median: -2.01% win: 40% σ: 3.52% n: 5 2022-04-12 → 2026-07-31 | PSCH Jun avg: 3.19% median: -0.89% win: 40% σ: 7.49% n: 5 2022-04-12 → 2026-07-31 | PSCH Jul avg: 3.19% median: 1.95% win: 80% σ: 6.09% n: 5 2022-04-12 → 2026-07-31 | PSCH Aug avg: -0.89% median: -2.35% win: 50% σ: 7.20% n: 4 2022-04-12 → 2026-07-31 (current) | PSCH Sep avg: -4.24% median: -4.25% win: 25% σ: 4.40% n: 4 2022-04-12 → 2026-07-31 | PSCH Oct avg: -1.37% median: -1.87% win: 50% σ: 5.19% n: 4 2022-04-12 → 2026-07-31 | PSCH Nov avg: 6.60% median: 6.55% win: 100% σ: 3.62% n: 4 2022-04-12 → 2026-07-31 | PSCH Dec avg: -0.73% median: -4.95% win: 25% σ: 10.50% n: 4 2022-04-12 → 2026-07-31 |
Metrics matched 71 tickers across 76 holdings rows (92.2% of fund weight). Metrics as of 2026-08-24; holdings from the filing.
Holdings of PSCH currently on TickerStance stock-RS leaderboards.
Position changes from the to the N-PORT filing.
| Holding | Before → after | Δ weight |
|---|---|---|
| MOHMolina Healthcare, Inc. | — → 4.77% | — |
| ALHCAlignment Healthcare, Inc. | — → 1.31% | — |
| LFSTLifeStance Health Group, Inc. | — → 0.93% | — |
| Holding | Before → after | Δ weight |
|---|---|---|
| BTSGBrightSpring Health Services, Inc. | 2.80% → 4.35% | +1.55 pp |
| CORTCorcept Therapeutics Inc. | 1.99% → 3.47% | +1.48 pp |
| ALKSAlkermes PLC |
| 2.96% → 3.71% |
| +0.75 pp |
| OGNOrganon & Co. | 1.13% → 1.85% | +0.72 pp |
| ASTHAstrana Health, Inc. | 0.52% → 0.87% | +0.34 pp |
+17 more
| Holding | Before → after | Δ weight |
|---|---|---|
| TMDXTransMedics Group, Inc. | 2.96% → 1.22% | −1.73 pp |
| ADMAADMA Biologics, Inc. | 2.21% → 1.01% | −1.19 pp |
| GKOSGlaukos Corp. | 4.12% → 3.17% | −0.95 pp |
| RDNTRadNet, Inc. | 2.89% → 2.06% | −0.82 pp |
| PBHPrestige Consumer Healthcare Inc. | 1.98% → 1.20% | −0.79 pp |
+44 more
| Holding | Before → after | Δ weight |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | 1.28% → — | — |
| MYGNMyriad Genetics, Inc. | 0.26% → — | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.